Farallon Capital Management’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$345K Hold
4,000
﹤0.01% 113
2025
Q4
$349K Hold
4,000
﹤0.01% 102
2025
Q3
$229K Sell
4,000
-206,000
-98% -$11.9M ﹤0.01% 115
2025
Q2
$12.4M Buy
210,000
+127,000
+153% +$8.21M 0.05% 79
2025
Q1
$6.08M Buy
83,000
+79,400
+2,206% +$6.56M 0.03% 79
2024
Q4
$298K Hold
3,600
﹤0.01% 114
2024
Q3
$258K Hold
3,600
﹤0.01% 125
2024
Q2
$247K Buy
+3,600
New +$215K ﹤0.01% 124

Other funds holding GMED

Farallon Capital Management's GMED Position: Q1 2026 in Review

Farallon Capital Management held its Globus Medical (GMED) position steady in Q1 2026 at 4,000 shares worth $345K. The position accounts for ﹤0.01% of the portfolio, ranked #113.

Farallon Capital Management first reported a position in GMED in Q2 2024 and has held it in 8 quarters since. The position peaked at $12.4M in Q2 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

  • Farallon Capital Management held 4,000 shares of Globus Medical worth $345K as of Q1 2026.
  • Farallon Capital Management left its Globus Medical share count unchanged in Q1 2026.
  • Globus Medical made up ﹤0.01% of Farallon Capital Management's portfolio in Q1 2026, its #113 holding.
  • Farallon Capital Management first reported a position in Globus Medical in Q2 2024 and has held it in 8 quarters since.
  • Farallon Capital Management's Globus Medical position peaked at $12.4M in Q2 2025.
  • 602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.